US-based healthcare company electroCore has raised $40m from Merck's Global Healthcare Innovation Fund. Other participants in the round of financing are private equity groups including Easton Capital and Core Ventures. The company will ...
Tags: Electrocore, Therapy Device, Medicine
ElectroCore has initiated enrolling patients in a clinical trial of its GammaCore nVNS therapy, designed for preventing chronic migraine. The easy-to-use, non-invasive device, which enables self-administration of therapy, stimulates ...